Guangdong Marubi Biotechnology Co.,Ltd.’s Net Profit Rose 15.5% in First Half of 2023

Guangdong Marubi Biotechnology Co.,Ltd. (广东丸美生物技术股份有限公司) (603983.SH) reported a net profit of 131.4 million yuan in the first half of 2023, up 15.5% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 29.6% year-on-year.

At the end of the reporting period, it had 4.2 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 22.8%.